In 2016, one of WGHA’s executive members contacted us about connecting with other organizations working on antimicrobial resistance (AMR). AMR has led to the emergence of so-called “superbugs”—infections that are resistant to existing drugs. In less than 2 weeks, we convened more than two dozen AMR experts from around the state, who shared their perspectives on tracking resistance, the need for quick diagnostic tools, and the challenges faced by hospitals in Seattle and around the world.
The participants—including researchers and leaders from hospitals, universities, research institutes, the U.S. military, and state and county departments of health—agreed to form a statewide coalition to address AMR. Together, they are working to secure funding for strategies ranging from drug development to global surveillance. The diversity of the coalition participants and their willingness to gather in the spirit of cooperation rather than competition are hallmarks of the WGHA approach to collaboration.